CHEMPLUSCHEM
FULL PAPERS
zofuryl), 7.16 (ddt, J6,7 =8.1, J6,4 =2.0, J6,3 =0.7 Hz, 1H; H-6-dihydro-
benzofuryl), 7.31 (dtd, J4,6 =2.0, J4,3 =1.1, J4,7 =0.5 Hz, 1H; H-4-dihy-
drobenzofuryl), 7.40 (s, 1H; H-6), 8.12 ppm (s, 1H; H-2); 13C NMR
(125.7 MHz, [D6]DMSO): d=29.33 (CH2-3-dihydrobenzofuryl), 39.82
(CH2-2’), 62.21 (CH2-5’), 71.27 (CH2-2-dihydrobenzofuryl), 71.28 (CH-
3’), 83.06 (CH-1’), 87.50 (CH-4’), 100.77 (C-4a), 109.35 (CH-7-dihydro-
benzofuryl), 116.70 (C-5), 120.11 (CH-6), 125.64 (CH-4-dihydroben-
zofuryl), 126.65 (C-5-dihydrobenzofuryl), 128.34 (C-3a-dihydroben-
zofuryl), 128.39 (CH-6-dihydrobenzofuryl), 150.35 (C-7a), 151.73
(CH-2), 157.44 (C-4), 159.17 ppm (C-7a-dihydrobenzofuryl); IR (KBr):
n˜ =3332, 3191, 2929, 2860,1493, 1300, 1223, 1093, 1050 cmÀ1; MS
(ESI+): m/z (%): 369.2 (100) [M++H]; HRMS (ESI+): m/z calcd for
C19H21N4O4: 369.15573; found: 369.15575.
19.2 Hz; Pa), À6.65 ppm (d, J=19.8 Hz; Pg); MS (ESI+): m/z (%):
611.1 (8) [M++H]; 633.0 (20) [M++Na]; HRMS (ESI+): m/z calcd for
C18H22O14N4P3:
611.03508;
found: 611.03483;
calcd
for
C18H21O14N4NaP3: 633.01703; found: 633.01664.
dCDHBTP: Compound dCDHBTP was prepared from dCITP according
to the general procedure (Method B). The product was isolated as
a white solid (17 mg, 41%). 1H NMR (500.0 MHz, D2O, pD=7.1,
phosphate buffer, ref(dioxane)=3.75 ppm): d=2.35 (ddd, Jgem
14.1, J2’b,1’ =7.5, J2’b,3’ =6.4 Hz, 1H; H-2’b), 2.42 (ddd, Jgem =14.1,
2’a,1’ =6.3, J2’a,3’ =3.6 Hz, 1H; H-2’a), 3.28 (t, J3,2 =8.7 Hz, 2H; H-3-di-
hydrobenzofuryl), 4.15 (m, 2H; H-5’), 4.21 (m, 1H; H-4’), 4.61 (dt,
3’,2’ =6.4,. 3.6, J3’,4’ =3.6 Hz, 1H; H-3’), 4.64 (t, J2,3 =8.7 Hz, 2H; H-2-
dihydrobenzofuryl), 6.35 (dd, J1’,2’ =7.5, 6.3 Hz, 1H; H-1’), 6.91 (d,
7,6 =8.2 Hz, 1H; H-7-dihydrobenzofuryl), 7.18 (dd, J6,7 =8.2, J6,4
=
J
J
dADHBTP: Compound dADHBTP was prepared from dAITP according
to the general procedure (Method B). The product was isolated as
a purple solid (14 mg, 42%). 1H NMR (499.8 MHz, D2O, pD=7.1,
J
=
2.0 Hz, 1H; H-6-dihydrobenzofuryl), 7.31 (d, J4,6 =2.0 Hz, 1H; H-4-di-
hydrobenzofuryl), 7.70 ppm (s, 1H; H-6); 13C NMR (125.7 MHz, D2O,
pD=7.1, phosphate buffer, ref(dioxane)=69.3 ppm): d=31.62
(CH2-3-dihydrobenzofuryl), 41.59 (CH2-2’), 68.03 (d, JC,P =5.4 Hz;
CH2-5’), 73.37 (CH-3’), 74.76 (CH2-2-dihydrobenzofuryl), 88.16 (d,
phosphate buffer, ref(dioxane)=3.75 ppm): d=2.46 (ddd, Jgem
14.0, J2’b,1’ =6.2, J2’b,3’ =3.2 Hz, 1H; H-2’b), 2.72 (ddd, Jgem =14.0,
2’a,1’ =7.8, J2’a,3’ =6.6 Hz, 1H; H-2’a), 3.76 (t, J3,2 =8.7 Hz, 2H; H-3-di-
=
J
hydrobenzofuryl), 4.11 (ddd, Jgem =11.0, JH,P =5.0, J5’b,4’ =4.4 Hz, 1H;
H-5’b), 4.17 (ddd, Jgem =11.0, JH,P =6.4, J5’a,4’ =4.4 Hz, 1H; H-5’a),
4.24 (bq, J4’,5’ =J4’,3’ =4.4 Hz, 1H; H-4’), 4.63 (t, J2,3 =8.7 Hz, 2H; H-2-
dihydrobenzofuryl), 4.80 (m, 1H; H-3’ overlapped with HDO signal),
6.66 (dd, J1’,2’ =7.8, 6.2 Hz, 1H; H-1’), 6.90 (d, J7,6 =8.2 Hz, 1H; H-7-
dihydrobenzofuryl), 7.24 (dd, J6,7 =8.2, J6,4 =1.7 Hz, 1H; H-6-dihy-
drobenzofuryl), 7.35 (d, J4,6 =2.0 Hz, 1H; H-4-dihydrobenzofuryl),
7.42 (s, 1H; H-6), 8.15 ppm (s, 1H; H-2); 13C NMR (125.7 MHz, D2O,
pD=7.1, phosphate buffer, ref(dioxane)=69.3 ppm): d=31.67
(CH2-3-dihydrobenzofuryl), 40.92 (CH2-2’), 68.27 (d, JC,P =5.5 Hz;
CH2-5’), 73.88 (CH-3’), 74.69 (CH2-2-dihydrobenzofuryl), 85.42 (CH-
1’), 87.76 (d, JC,P =8.7 Hz; CH-4’), 103.88 (C-4a), 112.16 (CH-7-dihy-
drobenzofuryl), 121.05 (C-5), 122.29 (CH-6), 128.57 (CH-4-dihydro-
benzofuryl), 128.96 (C-5-dihydrobenzofuryl), 131.27 (CH-6-dihydro-
benzofuryl), 131.45 (C-3a-dihydrobenzofuryl), 152.37 (C-7a), 153.90
(CH-2), 159.88 (C-4), 161.24 ppm (CH-7a-dihydrobenzofuryl);
31P NMR (202.3 MHz, D2O, pD=7.1, phosphate buffer, ref(phos-
phate buffer)=2.35 ppm): d=À21.53 (t, J=19.6 Hz; Pb), À10.55 (d,
J=19.6 Hz; Pa), À6.48 ppm (d, J=19.6 Hz; Pg); MS (ESI+): m/z (%):
629.0 (8) [M++Na]; 651.0 (20) [M++2Na]; HRMS (ESI+): m/z calcd
for C19H22O13N4P3: 607.04017; found: 607.04022; calcd for
C19H21O13N4NaP3: 629.02211; found: 629.02208.
JC,P =8.8 Hz; CH-4’), 88.62 (CH-1’), 112.38 (CH-7-dihydrobenzofuryl),
113.56 (C-5), 127.38 (C-5-dihydrobenzofuryl), 129.13 (CH-4-dihydro-
benzofuryl), 131.68 (C-3a-dihydrobenzofuryl), 131.96 (CH-6-dihydro-
benzofuryl), 142.03 (CH-6), 159.88 (C-2), 161.99 (CH-7a-dihydroben-
zofuryl), 167.79 ppm (C-4); 31P NMR (202.3 MHz, D2O, pD=7.1, re-
f(phosphate buffer)=2.35 ppm): d=À21.60 (t, J=19.7 Hz; Pb),
À10.74 (d, J=19.7 Hz; Pa), À6.63 ppm (d, J=19.7 Hz; Pg); MS
(ESI+): m/z (%): 628.0 (15) [M++2Na]; HRMS (ESI+): m/z calcd for
C17H21O14N3P3: 584.02418; found: 584.02419; calcd for
C17H20O14N3NaP3: 606.00613; found: 606.00623.
dCMOPTP: Compound dCMOPTP was prepared from dCI according to
the general procedure (Method C). The product was isolated as
a white solid (11 mg, 28%). 1H NMR (500.0 MHz, D2O, pD=7.1,
phosphate buffer, ref(dioxane)=3.75 ppm): d=2.36 (ddd, Jgem
14.0, J2’b,1’ =7.4, J2’b,3’ =6.4 Hz, 1H; H-2’b), 2.42 (ddd, Jgem =14.0,
2’a,1’ =6.4, J2’a,3’ =3.5 Hz, 1H; H-2’a), 3.89 (s, 3H; CH3O), 4.15 (m, 2H;
=
J
H-5’), 4.22 (td, J4’,5’ =4.4, J4’,3’ =3.5 Hz, 1H; H-4’), 4.60 (dt, J3’,2’ =6.4,.
3.5, J3’,4’ =3.5 Hz, 1H; H-3’), 6.35 (dd, J1’,2’ =7.4, 6.4 Hz, 1H; H-1’),
6.93 (dd, J6,5 =8.1, J6,2 =2.0 Hz, 1H; H-6-C6H3OHOMe), 7.02 (d, J5,6
=
8.1 Hz, 1H; H-5-C6H3OHOMe), 7.03 (d, 2,6 =2.0 Hz, 1H; H-2-
J
C6H3OHOMe), 7.71 ppm (s, 1H; H-6); 13C NMR (125.7 MHz, D2O,
pD=7.1, phosphate buffer, ref(dioxane)=69.3 ppm): d=41.59
(CH2-2’), 58.72 (CH3O), 68.05 (d, JC,P =5.5 Hz; CH2-5’), 73.41 (CH-3’),
88.18 (d, JC,P =8.7 Hz; CH-4’), 88.70 (CH-1’), 113.36 (C-5), 116.11 (CH-
2-C6H3OHOMe), 118.90 (CH-5-C6H3OHOMe), 125.22 (CH-6-
C6H3OHOMe), 127.33 (C-1-C6H3OHOMe), 142.12 (CH-6), 147.97 (C-4-
C6H3OHOMe), 150.42 (C-3-C6H3OHOMe), 159.88 (C-2), 167.73 ppm
(C-4); 31P NMR (202.3 MHz, D2O, pD=7.1, ref(phosphate buffer)=
2.35 ppm): d=À21.57 (t, J=19.6 Hz; Pb), À10.72 (d, J=19.6 Hz;
Pa), À6.60 ppm (d, J=19.6 Hz; Pg); MS (ESI+): m/z (%): 610.0 (15)
[M++H]; 653.9 (10) [M++Na]; HRMS (ESI+): m/z calcd for
C16H20O15N3P3: 610.00104; found: 610.00062; calcd for
C16H18O15N3Na3P3: 653.96493; found: 653.96465.
dAMOPTP: Compound dAMOPTP was prepared from dAITP according
to the general procedure (Method B). The product was isolated as
a purple solid (21 mg, 42%). 1H NMR (500.0 MHz, D2O, pD=7.1,
phosphate buffer, ref(dioxane)=3.75 ppm): d=2.46 (ddd, Jgem
=
14.0, J2’b,1’ =6.2, J2’b,3’ =3.0 Hz, 1H; H-2’b), 2.73 (ddd, Jgem =14.0,
J
J
J
2’a,1’ =8.1, J2’a,3’ =6.4 Hz, 1H; H-2’a), 3.88 (s, 3H; CH3O), 4.11 (ddd,
gem =10.7, JH,P =5.6, J5’b,4’ =4.4 Hz, 1H; H-5’b), 4.17 (ddd, Jgem =10.7,
H,P =6.3, J5’a,4’ =4.4 Hz, 1H; H-5’a), 4.24 (td, J4’,5’ =4.4, J4’,3’ =3.0 Hz,
1H; H-4’), 4.76 (dt, J3’,2’ =6.4, 3.0, J3’,4’ =3.0 Hz, 1H; H-3’), 6.67 (dd,
1’,2’ =8.1, 6.2 Hz, 1H; H-1’), 6.98 (dd, J6,5 =8.0, J6,2 =1.7 Hz, 1H; H-6-
C6H3OHOMe), 7.01 (d, J5,6 =8.0 Hz, 1H; H-5-C6H3OHOMe), 7.10 (d,
J
J
2,6 =1.7 Hz, 1H; H-2-C6H3OHOMe), 7.45 (s, 1H; H-6), 8.16 ppm (s,
1H; H-2); 13C NMR (125.7 MHz, D2O, pD=7.1, phosphate buffer, ref-
(dioxane)=69.3 ppm): d=40.93 (CH2-2’), 58.73 (CH3O), 68.31 (d,
Materials for biochemistry
J
C,P =5.5 Hz; CH2-5’), 73.95 (CH-3’), 85.46 (CH-1’), 87.79 (d, JC,P =
Synthetic oligonucleotides (ONs) and unmodified nucleoside tri-
phosphates (dATP, dTTP, dCTP, and dGTP) were purchased from
Sigma, Dynabeads M-270 Streptavidin (DBStv) were obtained from
Dynal A.S. (Norway), Pwo polymerase was from New England Bio-
labs (Great Britain), KOD XL DNA from Novagen, and g-32P-ATP
from MP Empowered Discovery (USA). Other chemicals were of an-
alytical grade.
8.9 Hz; CH-4’), 103.82 (C-4a), 115.81 (CH-2-C6H3OHOMe), 118.68
(CH-5-C6H3OHOMe), 120.89 (C-5), 122.36 (CH-6), 124.55 (CH-6-
C6H3OHOMe), 128.93 (C-1-C6H3OHOMe), 147.14 (C-4-C6H3OHOMe),
150.38 (C-3-C6H3OHOMe), 152.40 (C-7a), 153.70 (CH-2), 159.86 ppm
(C-4); 31P NMR (202.3 MHz, D2O, pD=7.1, ref(phosphate buffer)=
2.35 ppm): d=À21.49 (dd, J=19.8, 19.2 Hz; Pb), À10.44 (d, J=
ꢁ 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
ChemPlusChem 0000, 00, 1 – 11
&
8
&
ÞÞ
These are not the final page numbers!